Melodiol Global Health Limited

Equities

ME1

AU0000282840

Pharmaceuticals

Market Closed - Australian S.E. 11:40:50 30/05/2024 am IST 5-day change 1st Jan Change
0.001 AUD -66.67% Intraday chart for Melodiol Global Health Limited -50.00% -97.50%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50% MT
Melodiol Global's Revenue Surges 79% in Q1 MT
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic MT
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million MT
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces MT
Melodial's Unit Logs AU$1 Million Revenues in January MT
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary CI
Melodiol Global Health Limited Reports Unaudited Revenue Results for the Nine Months of 2023 CI
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October MT
Melodiol Global Health Achieves 80% Remission Rate from Phase Two Hallucinogenic Trial MT
Melodial's Canadian Arm Mernova Logs Record Sales in Q3 MT
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million. CI
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders MT
Melodiol Global Health Limited Announces Revenue Results for Third Quarter of 2023 CI
Melodiol Global Health Triples Q2 Net Sales MT
Creso Pharma Changes Name to Melodiol Global Health MT
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia MT
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe MT
Creso Pharma Raises AU$2.5 Million Via Share Issue MT
ASX Halts Creso Pharma's Trading Amid Pending Announcement MT
Health House International to be Removed from Australian Bourse's Official List MT
Creso Pharma Limited completed the acquisition of Health House International Limited. CI
Creso Pharma Expands Pet Care Range to Asia with Distribution Deals MT
Chart Melodiol Global Health Limited
More charts
Melodiol Global Health Limited is an Australia-based cannabis company. The Company develops cannabis, hemp-derived and other plant-based therapeutic, nutraceutical, and lifestyle products. The Company distributes pharmaceuticals internationally, specializing in the distribution of medicinal cannabis products across Australasia, and non-cannabis products in the United Kingdom and Europe. It also develops and sells beauty and personal care products, produced using plant-based processes, including under the brands Green Goo, Southern Butter and Good Goo. Its segments include Europe, Canada and Asia Pacific. Its Europe segment includes Health House International Limited (HHI), UK division, which distributes pharmaceutical products, and Creso Pharma Switzerland GmbH, which includes the development and commercialization of its nutraceutical products located in Switzerland. Its Canada segment includes Mernova Medicinal Inc, a producer of cannabis products and sells under the Ritual brand.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. ME1 Stock
  4. News Melodiol Global Health Limited
  5. Creso Pharma Acquisition Target Sierra Sage Herbs Raises US Distribution Footprint; Shares Fall 4%